15 Best Strong Buy Stocks to Invest In
Top economic experts in the United States have warned of the US economy slipping into a recession in 2023 despite recent numbers from the government that indicate the economy might be on a rebound path...
Apellis Pharmaceuticals Inc. (APLS)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | VenBio Select Advisor Kurt Von Emster | 10,125,000 | $691,538 | +4% | 12.77% |
| 2. | EcoR1 Capital Oleg Nodelman | 5,183,431 | $354,028 | 10.44% | |
| 3. | Octagon Capital Advisors Ting Jia | 2,503,059 | $170,959 | -4% | 29.5% |
| 4. | Cormorant Asset Management Bihua Chen | 1,478,000 | $100,947 | +56% | 7.05% |
| 5. | 51,885,000 | $99,115 | 1.97% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $40.00 | 250,000 | Large Shareholder | 12,806,342 | 2021-11-18 | Filing | |
| $31.81 | 5,000 | Director | 5,000 | 2020-05-08 | Filing | |
| $37.00 | 540,540 | Large Shareholder | 12,556,342 | 2020-01-13 | Filing | |
| $29.71 | 11,699 | Officer | 11,699 | 2019-08-29 | Filing | |
| $17.00 | 441,176 | Large Shareholder | 12,015,802 | 2019-03-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $49.93 | 500 | Director | 129,430 | 2022-12-01 | Filing | |
| $49.93 | 2,500 | Officer | 97,384 | 2022-12-01 | Filing | |
| $48.01 | 1,250 | Director | 263,774 | 2022-11-15 | Filing | |
| $46.47 | 12,000 | Officer | 963,780 | 2022-11-08 | Filing | |
| $58.54 | 5,000 | Officer | 42,907 | 2022-11-03 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 12,500,000 | $24,423,875 | 0.01% | |
| 2. | 168,971 | $11,540,719 | 0.12% | |
| 3. | 115,362 | $7,879,225 | 0.01% | |
| 4. | 69,158 | $4,723,491 | 0% | |
| 5. | 9,957,416 | $680,091 | 0.14% |
News See All
Top 10 Stock Picks of Frank Fu's CaaS Capital
In this article, we discuss the top 10 stock picks of Frank Fu's CaaS Capital.
Analysts Are Downgrading These 5 Pharmaceutical Stocks
In this article, we present the 5 pharmaceutical stocks that are being downgraded by analysts.
12 Best US Stocks to Buy Now
All major stock benchmarks saw their highest losses in two years in the first quarter of 2022, with the S&P 500 declining 4.6% and the Nasdaq Composite falling 9%.
Did Hedge Funds Get Apellis Pharmaceuticals, Inc. (APLS) Right?
Stocks, especially the once high flying technology stocks, had a lousy start to the new year. QQQ lost 9% of its value in January.
Do Hedge Funds Love Apellis Pharmaceuticals, Inc. (APLS)?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of every quarter.
Is Apellis Pharmaceuticals, Inc. (APLS) Going to Burn These Hedge Funds?
In this article we are going to use hedge fund sentiment as a tool and determine whether Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) is a good investment right now.
Where Do Hedge Funds Stand On Apellis Pharmaceuticals, Inc. (APLS)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is APLS Stock A Buy or Sell?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Apellis Pharmaceuticals, Inc. (APLS): Hedge Funds Taking Some Chips Off The Table
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Billionaire Hedge Funds
